Displaying 201 - 210 of 620
Canadian Association of Psychosocial Oncology (CAPO) 2025: Care of the soul in cancer
Updated:
LLSC was delighted to have the opportunity to participate again in the annual conference of the Canadian Association of Psychosocial Oncology (CAPO), in Toronto April 2025.
Events, Partners
Addressing the global Pegasys® shortage
Updated:
Following Health Canada’s decision to grant ropeginterferon (BESREMi®) exceptional importation status, some of the provinces and private insurance plans have been starting to cover BESREMi® treatment. Work is continuing in the provinces where there is not yet coverage.
Advocacy, Partners, Myeloproliferative neoplasms
Image
Problems sleeping during and after treatment
Updated:
Cancer treatments can disrupt sleep. Find out how treatments can affect sleep and what strategies you can use to sleep better.
Treatment and side effects
Lori Galbraith: First Connection Volunteer of the Year 2024
Updated:
As we do every year at this time, we highlight one English-speaking volunteer (and one French-speaking volunteer) for outstanding contributions to our First Connection peer support programs.
Events, Stories, Volunteers, Leukemia
I have a blood cancer
Updated:
Get the support you need. Access one-on-one personalized support. Support groups. First connection peer support program.
I am a blood cancer survivor
Updated:
Get the support you need. Access one-on-one personalized support, Support groups, and First connection peer support program.
Monthly Donations
Updated:
The needs of a person facing a blood cancer are complex, and can be overwhelming. But how you choose to give can be a game changer.
LLSC & CANO formalize and extend collaboration
Updated:
To further extend their collaboration, raise awareness on blood cancers, and to formalize their commitment to their partnership, the CANO and The Leukemia & Lymphoma Society of Canada (LLSC) have signed a memorandum of understanding (MOU) represented by Pascale Rousseau,…
Events, Partners
Image
Immune effector cell-associated neurotoxicity syndrome (ICANS)
Updated:
Immune effector cell-associated neurotoxicity syndrome (ICANS) is a side effect that can happen after some forms of immunotherapy treatment. It may cause you to experience serious neurological symptoms.
Treatment and side effects
Image
Myelofibrosis (MF) therapies: From palliation to disease modification - myeloproliferative neoplasms (MPN) conference 2025
Updated:
Dr. Vikas Gupta, Hematologist at the Princess Margaret Cancer Centre in Toronto, reviewed Myelofibrosis (MF) and the evolution in diagnosis, treatment options and aspects of follow-up care in this 1-hour webcast as part of MPN Conference 2025.
Myeloproliferative neoplasms